66 related articles for article (PubMed ID: 2892549)
1. Selected ion monitoring analysis of monoamine metabolites in cerebrospinal fluid. Application to the study of in vivo effects of alpha 2-antagonists.
Dillen L; Duchateau A; De Potter WP; Claeys M
Biomed Environ Mass Spectrom; 1987 Nov; 14(11):675-82. PubMed ID: 2892549
[TBL] [Abstract][Full Text] [Related]
2. Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits.
Dillen L; Claeys M; De Potter WP
Eur J Pharmacol; 1987 May; 137(1):33-40. PubMed ID: 2440704
[TBL] [Abstract][Full Text] [Related]
3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
4. Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid.
Scheinin H; Virtanen R
Life Sci; 1986 Oct; 39(16):1439-46. PubMed ID: 2430157
[TBL] [Abstract][Full Text] [Related]
5. Selected ion monitoring assay for biogenic amine metabolites and probenecid in human lumbar cerebrospinal fluid.
Faull KF; Anderson PJ; Barchas JD; Berger PA
J Chromatogr; 1979 Aug; 163(4):337-49. PubMed ID: 544601
[TBL] [Abstract][Full Text] [Related]
6. An extraction-derivatization method suitable for the analysis of biogenic amines by gas chromatography negative ion mass spectrometry.
Midgley JM; MacLachlan J; Watson DG
Biomed Environ Mass Spectrom; 1988 May; 15(10):535-9. PubMed ID: 3408822
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
8. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines.
Marín-Valencia I; Serrano M; Ormazabal A; Pérez-Dueñas B; García-Cazorla A; Campistol J; Artuch R
Clin Biochem; 2008 Nov; 41(16-17):1306-15. PubMed ID: 18790694
[TBL] [Abstract][Full Text] [Related]
9. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
[TBL] [Abstract][Full Text] [Related]
10. Rearing experience and biogenic amine activity in infant rhesus monkeys.
Clarke AS; Hedeker DR; Ebert MH; Schmidt DE; McKinney WT; Kraemer GW
Biol Psychiatry; 1996 Sep; 40(5):338-52. PubMed ID: 8874834
[TBL] [Abstract][Full Text] [Related]
11. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of biogenic amines and related compounds by high performance liquid chromatography (HPLC).
Shibuya T; Sato K; Salafsky B
Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):297-301. PubMed ID: 7107080
[TBL] [Abstract][Full Text] [Related]
13. Validation of a method to detect cocaine and its metabolites in nails by gas chromatography-mass spectrometry.
Valente-Campos S; Yonamine M; de Moraes Moreau RL; Silva OA
Forensic Sci Int; 2006 Jun; 159(2-3):218-22. PubMed ID: 16183230
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
15. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
[TBL] [Abstract][Full Text] [Related]
16. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
18. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
19. Methodology for the identification of the urinary metabolites of the analgesic-narcotic antagonist, codorphone, by gas chromatography mass spectrometry.
Evans JV; Leeling JL; Helms RJ
Biomed Mass Spectrom; 1982 May; 9(5):191-200. PubMed ID: 6124285
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma screening: labeling of HVA and VMA for stable isotope dilution gas chromatography-mass spectrometry.
Gleispach H; Huber E; Fauler G; Kerbl R; Urban C; Leis HJ
Nutrition; 1995; 11(5 Suppl):604-6. PubMed ID: 8748233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
